Mark A. Meltz
General Counsel · Lyell Immunopharma, Inc.
Individual
- 2026
- Feb 12, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark A. Meltz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ARCH Venture Fund XIII, L.P. - $12.50M in LYEL purchases and sales in the last 12 months
- ARCH Venture Partners IX, LLC - $12.50M in LYEL purchases and sales in the last 12 months
- Lynn Seely - $353K in LYEL purchases and sales in the last 12 months
- Gary K. Lee - $72K in LYEL purchases and sales in the last 12 months
- Stephen J. Hill - $51K in LYEL purchases and sales in the last 12 months
- David Shook - $31K in LYEL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark A. Meltz?
Mark A. Meltz is a corporate insider, tracked as General Counsel of Lyell Immunopharma, Inc. (LYEL). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mark A. Meltz last file a Form 4?
The only primary Form 4 on record is dated 12 February 2026.